CDK5 and mantle cell lymphoma: Genetic and pharmacologic (GFB-12811) manipulation of CDK5 in MCL cell lines revealed that CDK5 contributed to proliferation and ibrutinib resistance <i>in vitro</i>, while engineered expression of CDK5 in JeKo-1 cells shortened survival in a murine xenograft model.